BOSTON (CBS) – Johnson & Johnson is now testing its COVID-19 vaccine on teenagers.

The company announced Friday it’s testing the vaccine in a “small number” of kids ages 16 and 17. The study will then be expanded to a larger group of children as young as 12.

READ MORE: LIST: These Retailers Have Updated Their Face Mask Policies For Customers, Employees

This trial is currently enrolling participants in Spain and the United Kingdom and will begin soon in the U.S.

READ MORE: Moving Truck 'Storrowed' Near Mass General, Causing Traffic Delays

Johnson & Johnson’s single-shot vaccine is currently approved for emergency use in the U.S. for anyone 18 and older.

Pfizer said on Wednesday its two-dose vaccine is 100-percent effective in kids ages 12 to 15. It’s vaccine is approved for emergency use in anyone age 16 or older.

MORE NEWS: COVID Vaccine Mandate Ordered For All Nursing Home Workers In Massachusetts

Earlier this month, Cambridge-based Moderna started a study of its coronavirus vaccine in children under the age of 12. Staff